Briefing
Prognostic value of circulating tumor DNA for minimal residual disease detection in ovarian cancer: A systematic review and meta-analysis
Systematic review and meta-analysis of the prognostic value of ctDNA for MRD detection in ovarian cancer.
- Design: Evidence level 2
- Assay: Not named in the abstract
Crit Rev Oncol HematolPubMed 41895358DOI 10.1016/j.critrevonc.2026.105300